Search

Search Constraints

You searched for: Author/Creator Boni, Joseph

Search Results

1. Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study. Issue 6 (June 2021)

2. Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study. (August 2020)

3. Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma. Issue 3 (4th March 2018)

4. Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma. (1st January 2017)